Loading data for DMAA — first visit, this takes a few seconds.

Drugs Made In America Acq...

NasdaqGM: DMAA · 실시간 가격 · USD
10.72
+0.03 (0.28%)
종가 기준: Aug 18, 2026, 8:00 PM

Drugs Made In America Acquisition Corp. (DMAA) Stock Price, Analysis & Data

0.28%

데이터 없음

매수호가10.65
시가총액260.25M
매출 (ttm)n/a
순이익 (ttm)6.66M
베타n/a
EPS (ttm)0.18
P/E (ttm)59.56
선행 P/En/a
P/B (ttm)-49.86
P/S (ttm)n/a
Earnings Daten/a
매도호가10.54
거래량24,959
평균 거래량 (20일)35,809
시가10.72
전일 종가10.69
일중 범위10.72 - 10.72
52주 범위10.22 - 10.72
애널리스트n/a
목표주가n/a
배당n/a
배당락일n/a

DMAA 소개

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York....

IPO 일자 Feb 25, 2025
직원 수 n/a
상장 거래소 NasdaqGM
티커 DMAA
전체 기업 정보

재무 실적

2025년 Drugs Made In America Acquisition의 매출은 0로, 전년 n/a 대비 undefined% 증가했습니다. 순이익은 5.94M로, undefined% 증가했습니다.

재무제표